Metacrine Inc (MTCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||
| Net Income | -8,112 | -28,933 | -21,536 |
| Depreciation Amortization | 220 | 830 | 619 |
| Accounts payable and accrued liabilities | -1,190 | N/A | 1,646 |
| Other Working Capital | -1,330 | -1,019 | 1,361 |
| Other Operating Activity | 1,810 | 1,374 | -760 |
| Operating Cash Flow | $-8,602 | $-27,748 | $-18,670 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | 5,746 | N/A | 11,398 |
| PPE Investments | -73 | -84 | -56 |
| Other Investing Activity | 0 | 17,781 | 0 |
| Investing Cash Flow | $5,673 | $17,697 | $11,342 |
| Cash Flows From Financing Activities | |||
| Debt Issued | N/A | N/A | 9,717 |
| Common Stock Issued | 3 | N/A | 30 |
| Common Stock Repurchased | -2 | N/A | -1 |
| Other Financing Activity | -10 | 9,754 | 0 |
| Financing Cash Flow | $-9 | $9,754 | $9,746 |
| Beginning Cash Position | 15,668 | 15,965 | 15,965 |
| End Cash Position | 12,730 | 15,668 | 18,383 |
| Net Cash Flow | $-2,938 | $-297 | $2,418 |
| Free Cash Flow | |||
| Operating Cash Flow | -8,602 | -27,748 | -18,670 |
| Capital Expenditure | -73 | N/A | -56 |
| Free Cash Flow | -8,675 | -27,748 | -18,726 |